Lv21
118 积分 2025-09-23 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
4小时前
已完结
Positive thyroid autoantibodies in primary Sjögren syndrome define a subset of patients with milder disease
20天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
30天前
已完结
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
3个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
3个月前
已完结
[Standardized diagnosis and treatment of undifferentiated connective tissue disease and mixed connective tissue disease]
3个月前
已完结
[Guideline for the diagnosis and treatment of non-radiographic axial spondyloarthritis (2024 edition)]
3个月前
已完结
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
3个月前
已完结
[Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition)]
3个月前
已完结
BTK inhibitors and next-generation BTK-targeted therapeutics for B-cell malignancies
5个月前
已完结
皖公网安备34019202002308
